Antithrombotic therapy in the coronary vein graft patient
Key result
Various platelet inhibitors and anticoagulants play a role in the prevention of saphenous vein graft occlusion following coronary artery bypass grafting.
Why the study?
Do platelet inhibitors and anticoagulants prevent saphenous vein graft occlusion following coronary artery bypass grafting?
Population
Patients with coronary artery disease undergoing coronary artery bypass grafting with saphenous vein grafts
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports antithrombotic strategies post-CABG; leaves open optimal regimens pending randomized data.
Structured PICO
Do platelet inhibitors and anticoagulants prevent saphenous vein graft occlusion following coronary artery bypass grafting?
P
Population
Patients with coronary artery disease undergoing coronary artery bypass grafting with saphenous vein grafts
I
Intervention
Platelet inhibitors and anticoagulants
O
Outcome
Prevention of saphenous vein graft occlusion
This review describes the role of antithrombotic therapies in preventing early and late saphenous vein graft occlusion after CABG.
Cite This Study
Israel et al. (1991) conducted a review in Coronary artery disease. Platelet inhibitors and anticoagulants was evaluated. Various platelet inhibitors and anticoagulants play a role in the prevention of saphenous vein graft occlusion following coronary artery bypass grafting.